Dr. Huang Compares Surveillance and Treatment in Kidney Cancer

William C. Huang, MD
Published: Monday, Feb 18, 2013

William C. Huang, MD, assistant professor in the Department of Urology at New York University Langone Medical Center, discusses findings from a SEER database analysis that compared surveillance to surgical resection in elderly patients with small renal masses.

Huang notes that a majority of small kidney tumors (<4 cm) are incidental findings, which may not pose a threat to patients. For these patients, surveillance may be a reasonable alternative to treatment, since cardiovascular issues are common following surgical resection.

In the population-based study, 8317 patients were examined who were treated with surgery (78%) and surveillance (22%).  The risk of dying due to kidney cancer was not significantly different between the two arms, Huang explains. Moreover, surveillance was associated with a much lower risk of developing a cardiovascular event compared to surgery (HR = 0.51; 95% CI, 0.44 — 0.60; P > .00001).

<<< View coverage from the 2013 GU Cancers Symposium

William C. Huang, MD, assistant professor in the Department of Urology at New York University Langone Medical Center, discusses findings from a SEER database analysis that compared surveillance to surgical resection in elderly patients with small renal masses.

Huang notes that a majority of small kidney tumors (<4 cm) are incidental findings, which may not pose a threat to patients. For these patients, surveillance may be a reasonable alternative to treatment, since cardiovascular issues are common following surgical resection.

In the population-based study, 8317 patients were examined who were treated with surgery (78%) and surveillance (22%).  The risk of dying due to kidney cancer was not significantly different between the two arms, Huang explains. Moreover, surveillance was associated with a much lower risk of developing a cardiovascular event compared to surgery (HR = 0.51; 95% CI, 0.44 — 0.60; P > .00001).

<<< View coverage from the 2013 GU Cancers Symposium




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x